Effective
Treatments for Vaccine Effects
(Millions injured by the vaccines and needing help,
mostly being ignored by Medical Authorities and most doctors) (Pfizer data showed
1200 deaths from vaccine in clinical trial but FDA didn’t follow their policy
on such and pull the vaccine like they have for some others. There was never a clinic trial or
study that proved the vaccines were safe or effective.).
Vitamin
D Replacement Therapy Helps COVID Vax Injured with ME/CFS and
other effects.
Reasonable Informed Consent
and Health Authority Warnings that Vitamin D status is important for ME/CFS and other conditions could also have prevented millions
of cases of symptoms from Long Vax or Long Covid.
Effective Treatments for
Covid (CVTreat)
are also beneficial for Vaccine Effects
D-Dimer
as a Biomarker for Acute Pericarditis or Thrombotic Events :
Insights and
Future Directions
DD levels were found to
increase earlier than CRP, making it a potentially faster indicator of
inflammation. Elevated DD was associated with more severe AP features,
including higher heart rates and lower blood pressure. The findings suggest
that DD could reduce unnecessary imaging tests like CT pulmonary angiography
(CTPA), which increases healthcare costs and poses risks to renal function.
Researchers develop new blood test capable of quickly and accurately detecting stroke (D-Dimer)
D-dimer can indicate blood
clotting problems. D-dimer can be elevated due to inflammation, bleeding, or
other factors like COVID-19 infection or Covid Vaccine Spike Protein.
They found that combining the levels of the biomarkers
GFAP and D-dimer with FAST-ED data less than six hours from the onset of
symptoms allowed the test to detect LVO strokes with 93 percent specificity and
81 percent sensitivity. Other findings included that the test ruled out all
patients with brain bleeds, signaling that the technology may ultimately also
be employed to detect intracerebral hemorrhage in the field.
Berlin
Study Exposes Gaps in Post-COVID and Post-Vaccine Syndrome Treatment (PCS
& PVS)
The pathophysiology of PCS and PVS is strikingly
similar, according to the study,
GPCR Autoantibodies (80–90% of patients): triggered by exposure to the spike protein, bind to critical receptors such as ACE2, adrenergic, and muscarinic receptors, leading to dysautonomia, myopathy, chronic fatigue, and cognitive dysfunction.
Spike Protein Persistence (15–30% of patients): linked to vascular
inflammation, cognitive impairment, and exercise intolerance.
Microthrombosis
(5–15% of patients): clogging of microcapillaries with fibrin
deposits, leading to poor oxygenation, organ stress, and systemic inflammation.
Spike Protein Elimination
Therapy: four-drug regimen combining Ivermectin,
Nattokinase, Bromelain, and Acetylcysteine is used to
clear spike protein from the bloodstream.
Monocyte-targeted Therapy: When spike protein
is found in CX3CR1 monocytes, an HIV drug (Maraviroc, a CCR5 inhibitor) is
administered for 2–4 weeks.
Exosome Disruption: hyperthermia therapy
(whole-body heating to 39.5°C) is combined with standard treatments to disrupt
these vesicles.
Autoantibody Removal: with high GPCR
autoantibody loads, Immunoadsorption Apheresis (IA) is used to filter harmful
autoantibodies from the blood over five sessions within two weeks.
Microthrombosis Management: Patients with
vascular damage undergo anticoagulation therapy, using Clopidogrel or Direct
Oral Anticoagulants (DOACs).
Patients
with Vaccine Injuries or Long COVID Turn to Peptide Therapies Amid Regulatory
Hurdle
IMA Independent Medical Alliance
Prevention
Protocols (I -Prevent Vaccine Injury and I-Prevent Covid, RSV, Flu)
Treatment
Protocols (MATH+ Covid Treatment Protocol,/ I-CARE
RSV,Flu/ I-CARE for KIDS/
I-CARE EARLY COVID TREATMENT)
Recovery Protocols
(I-Recover: Post Vaccine Treatment, ( I Recover: Long
Covid Treatment)
Other Condition Treatment Protocol
(Depression, Cancer, Brain Conditions, Sepsis, Insulin Resistance, Healthy
Eating Guide)
IVERMECTIN PROVEN HIGHLY
EFFECTIVE IN TREATING COVID IN CLINICAL TRIAL
Combination
Therapy For COVID-19 Based on Ivermectin in an Australian Population
Effective Treatments for
Covid are also beneficial for Vaccination Injury
The study by Lacout et al. hypothesizes that hydroxychloroquine,
particularly when used early and at appropriate doses, was an effective
treatment for COVID-19, but was systematically discredited due to flawed
studies, scientific bias, and potential conflicts of interest. The authors
contend that regulatory agencies and the media actively suppressed HCQ's
potential benefits, instead favoring expensive, patented pharmaceuticals with
questionable efficacy.
This study and other studies and
data support this hypothesis.
